ISPOR’s 2nd PLENARY OF 18th ANNUAL EUROPEAN CONGRESS EXPLORES EVOLUTION OF OUTCOMES RESEARCH IN HEALTH CARE

Published Nov 10, 2015

PANEL EXAMINES OUTCOMES RESEARCH IN DAILY PRACTICE 

Milan, Italy—November 10, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress second plenary session — Outcomes Research: Are We Ready to Put Theory into Practice? — was held this morning at the MiCo – Milano Congressi in Milan, Italy. The plenary was moderated by Lorenzo G Mantovani, DSc, Associate Professor of Public Health, Center for Public Health Research (CESP), University of Milano-Bicocca, Monza, Italy and featured speakers: - Walter Ricciardi, President, Italian National Institute of Health (ISS) and Past-President, European Public Health Association (EUPHA), Rome, Italy - Sergio Pecorelli, MD, PhD, Chairman of the Board, Italian Medicines Agency (AIFA) and Professor, Department of Obstetrics and Gynecology, & Chancellor, University of Brescia, Brescia, Italy - Brian O'Rourke, PharmD, President and Chief Executive Officer, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada - Mario Strazzabosco, MD, PhD, Deputy Director, Yale Liver Center & Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine and Director, Department of Surgical and Interdisciplinary Medicine, University of Milano-Bicocca, Monza, Italy The Outcomes Research plenary explored the transition of outcomes research over the last four decades as assessment of outcomes has been moving from research into daily practice. The panel discussed current practices, challenges, and opportunities of outcomes research. The speakers also examined future perspectives on the assessment of outcomes in a variety of health care fields, including reimbursement of drugs and devices, evaluation of public health interventions, validation of new technologies, and financing of complex health services. “When evaluating putting outcomes research into practice we need to ask, ‘Is it new, is it true, and does it matter?’” Lorenzo G Mantovani, DSc. noted. Walter Ricciardi stated that, “We must put theory into practice during this very historic time.” He also spoke to the universality of health care, noting that, “All citizens will become patients at some point in their lives.” Sergio Pecorelli, MD, PhD remarked that, “The real answer is not simply to cut costs, but to see where the innovation is and to focus on long-term health planning.” Brian O'Rourke, PharmD emphasized that we should, “Change from patient reported outcomes to patient important outcomes.” And Mario Strazzabosco, MD, PhD stated, “What is the object of health care? Health. Not spending. Reimbursement should align with value.” Released presentations from the ISPOR 18th Annual European Congress are available at http://www.ispor.org/Event/ReleasedPresentations/2015Milan. ISPOR’s 18th Annual European Congress may be followed on social media using the hashtag #ISPORMilan.

###

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×